Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARA | P10276 | 1/20 | 0.42 |
| ▸ | RARB | P10826 | 1/20 | 0.42 |
| ▸ | CTRC | Q99895 | 2/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 2/20 | 0.38 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
| ▸ | KMO | O15229 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.36 |
| ▸ | UNG | P13051 | 1/20 | 0.36 |
| ▸ | RARG | P13631 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16559880 | 0.86 | CTRC (0.37) | CTRCMCL1F2F10DHODH | |
| SCHEMBL14758899 | 0.84 | RARA (0.53) | RARARARBCTRCMCL1CHEK1 | |
| SCHEMBL16488564 | 0.82 | DHODH (0.42) | AKR1C3DHODHMEN1KMT2A | |
| SCHEMBL16559879 | 0.81 | CTRC (0.37) | CTRCMCL1DHODHERN1 | |
| SCHEMBL16488563 | 0.81 | RXRA (0.50) | DHODHERN1 | |
| SCHEMBL16488560 | 0.81 | RXRA (0.50) | DHODHERN1 | |
| SCHEMBL17174087 | 0.79 | KMO (0.42) | AKR1C3DHODHERN1KMO | |
| SCHEMBL25551247 | 0.79 | RXRA (0.46) | DHODHMEN1KMT2A | |
| SCHEMBL19189206 | 0.79 | UNG (0.53) | RARARARBCTRCCHEK1DHODH | |
| SCHEMBL12349931 | 0.79 | CA12 (0.42) | AKR1C3MEN1KMT2AUNG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9421514-B2 | Porous materials containing built-in single molecule traps for small molecule capture | TEXAS A&M UNIVERSITY SYSTEM (US) | 2016-08-23 | — | — | US | disclosed |
| US-20150071845-A1 | Porous Materials Containing Built-In Single Molecule Traps for Small Molecule Capture | TEXAS A&M UNIVERSITY SYSTEM (US) | 2015-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150071845-A1 | Porous Materials Containing Built-In Single Molecule Traps for Small Molecule Capture | TRAP1, EPCAM, TEX264 | RARA 4701/4885RARB 4694/4885CTRC 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.